Nuvalent | IPO Presentation Deck | 40 slides · page 14 of 40
The slide uses a medical illustration to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to corresponding neurological and physiological side effects.
Pitch deck · problem_statement · frame_problem · dense density
Slide locked Sign in to view
Slide schematic 5/5
image 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 5
illustration bullet paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.